The largest US CDMO specializing in sterile Blow-Fill-Seal (BFS) technology for aseptic manufacturing of unit-dose medications. Based in Columbia, South Carolina with a 500,000+ sq ft facility and production capacity of over 2.6 billion units annually. Delivered more than 12 billion doses since 2012 with no patient interruptions. Provides both CDMO services and has a generics division. Offers the largest nebulized drug portfolio in the US. Key products include ophthalmic, respiratory, and inhalation medications. Has co-developed 80%+ of new BFS products over the past decade. 100% customer retention for 25 years. Recent investments include $17M cGMP lab expansion and seventh Syntegon packaging line. 16 FDA-approved products.
Blow-Fill-Seal (BFS) sterile aseptic manufacturing, unit-dose delivery, ophthalmic solutions, respiratory/inhalation solutions, nebulized drug formulation, extractables/leachables testing, generics manufacturing, clinical-to-commercial scale-up.
1 site worldwide
No reviews available yet.
No documents available.